The Study of Atherosclerosis With Ramipril and Rosiglitazone
Status:
Completed
Trial end date:
2006-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if ramipril and/or rosiglitazone retard the
progression of atherosclerosis as evaluated by serial carotid intermedial thickness
measurements.